Key facts
- It has raised $16.6M; the latest was PE Growth/Expansion in Oct 2024.
- Notable investors include Azimut Libera Impresa, Wellness Holding, InterAlpen Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for The Longevity Suite
- ·The full record, as it builds
Funding rounds
No funding rounds for The Longevity Suite are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About The Longevity Suite
Manufacturer of an anti-aging medicinal products intended to guide people toward a perfect balance between health and conscious beauty. The company offers longevity diagnostic and check-ups, cryotherapy, detox nutrition, and anti-age treatments and products thereby enabling users to regain well-being, energy, and fitness.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Milan, Italy
- Founded
- 2019
- Employees
- 123
- Website
- thelongevitysuite.com/
- Ownership
- Privately Held (backing)
The Longevity Suite doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in The Longevity Suite shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on The Longevity Suite in its N-PORT filings yet. We sweep new filings monthly.